NCT07121153View on ClinicalTrials.gov

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

January 11, 2026

Study Completion Date

January 11, 2026

Conditions
OverweightObesity
Interventions
DRUG

NNC0487-0111 A

Participants will receive single dose (level 1, level 2, level 3) injection of NNC0487-0111 A subcutaneoulsy.

DRUG

Placebo A

Participants will receive single dose (level 1, level 2, level 3) injection of placebo A subcutaneoulsy.

Trial Locations (1)

250000

RECRUITING

Jinan Central Hospital Affiliated to Shandong University, Ji'Nan

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY